ClinicalTrials.gg
Drug

Methoxydimethyltryptamines clinical trials

Also written 5-MeO-DMT and GH001.

studies test it
13
open now
0
in phase 3
0
first study started
2019

How each study uses Methoxydimethyltryptamines is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

5 Methoxy N,N Dimethyltryptamine
6
5-Methoxy-N,N-dimethyltryptamine
4

Development codes

GH001
7
BMND08
1
GH002
1

Other names

5-MeO-DMT
11
Mebufotenin
4

Studies by the year they started

13 studies that test it; most in 2023 (3)

Studies that test Methoxydimethyltryptamines, by start year
YearStudies
20192
20212
20222
20233
20242
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
9
Phase 2
6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 11 · Other 2

GH Research Ireland Limited (9) · Biomind Labs Inc. (1) · Usona Institute (1) · Beckley Psytech Limited (1) · Johns Hopkins University (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses Methoxydimethyltryptamines is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 13

Codes

What other systems call Methoxydimethyltryptamines · ClinicalTrials.gg INT007811

  • MeSH (NLM) D008732MethoxydimethyltryptaminesOne source NLM
  • UNII (FDA) X0MKX3GWU9MEBUFOTENINConfirmed FDA, NLM

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.